[go: up one dir, main page]

FR2946535B1 - Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale. - Google Patents

Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.

Info

Publication number
FR2946535B1
FR2946535B1 FR0953845A FR0953845A FR2946535B1 FR 2946535 B1 FR2946535 B1 FR 2946535B1 FR 0953845 A FR0953845 A FR 0953845A FR 0953845 A FR0953845 A FR 0953845A FR 2946535 B1 FR2946535 B1 FR 2946535B1
Authority
FR
France
Prior art keywords
neurone
gly
interaction
preventing
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0953845A
Other languages
English (en)
Other versions
FR2946535A1 (fr
Inventor
Gonzalez Marisa Teigell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUREVA
Original Assignee
NEUREVA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEUREVA filed Critical NEUREVA
Priority to FR0953845A priority Critical patent/FR2946535B1/fr
Priority to PCT/FR2010/051088 priority patent/WO2010142890A1/fr
Publication of FR2946535A1 publication Critical patent/FR2946535A1/fr
Application granted granted Critical
Publication of FR2946535B1 publication Critical patent/FR2946535B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0953845A 2009-06-10 2009-06-10 Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale. Expired - Fee Related FR2946535B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0953845A FR2946535B1 (fr) 2009-06-10 2009-06-10 Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.
PCT/FR2010/051088 WO2010142890A1 (fr) 2009-06-10 2010-06-03 Composition comprenant une molécule favorisant l'interaction neurone-glie, notamment pour prévenir la formation de la cicatrice gliale et induire la régénération neurale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0953845A FR2946535B1 (fr) 2009-06-10 2009-06-10 Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.

Publications (2)

Publication Number Publication Date
FR2946535A1 FR2946535A1 (fr) 2010-12-17
FR2946535B1 true FR2946535B1 (fr) 2011-09-09

Family

ID=41213337

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0953845A Expired - Fee Related FR2946535B1 (fr) 2009-06-10 2009-06-10 Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.

Country Status (2)

Country Link
FR (1) FR2946535B1 (fr)
WO (1) WO2010142890A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2998892B1 (fr) 2012-12-04 2015-01-02 Pf Medicament Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921076A (en) 1957-09-19 1960-01-12 Parke Davis & Co Heterocyclic compounds and methods for producing the same
EP0317953A3 (fr) * 1987-11-24 1990-12-05 G.D. Searle & Co. N-(1-Tihénylcycloalkyl)-alkényl-amines pour le traitement de maladies neurotoxiques
FR2639225B1 (fr) 1988-11-21 1993-05-21 Centre Nat Rech Scient Compositions pharmaceutiques pour la neuroprotection contenant des arylcyclohexylamines
FR2818147B1 (fr) 2000-12-20 2005-06-10 Sod Conseils Rech Applic Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine

Also Published As

Publication number Publication date
FR2946535A1 (fr) 2010-12-17
WO2010142890A1 (fr) 2010-12-16

Similar Documents

Publication Publication Date Title
LTC2444424I2 (lt) Pagerintos TM nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
CL2007003049A1 (es) Compuestos derivados de 2,4-diaminopirimidina; composicion farmaceutica, utiles para tratar trastornos proliferativos.
BR112012000254A2 (pt) análogos de tofa úteis no tratamento de distúrbios ou condições dermatológicas.
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
IL202674A0 (en) Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma
EP2196377A4 (fr) Bogie directeur pour matériel roulant, matériel roulant et véhicule articulé
CA118314S (en) Dispensing pump head
FR2932486B1 (fr) Procede de preparation d'un polyamideimide, polyamideimide et composition comprenant ce polyamideimide.
BRPI0822012A2 (pt) Derivados de quinazolina de 6,7-dialcóxi úteis para o tratamento de distúrbios relacionados com câncer
BRPI0816234A2 (pt) Derivado de ácido ascórbico ou sal do mesmo, método de produção do mesmo, e cosmético
BRPI0820440A2 (pt) Inibidores aldh-2 no tratamento de desordens psiquiátricas
WO2008108830A3 (fr) Compositions immunogènes et thérapeutiques pour streptococcus pyogenes
BRPI0808043A2 (pt) Compostos tricíclicos úteis no tratamento de distúrbios de ferro.
BRPI0922645A2 (pt) "arilamidas tiadiazol substituídas".
SI2266619T1 (sl) Farmacevtski sestavek na osnovi hepatoprotektorja in prebiotika, njegova izdelava in uporaba
EP2640398A4 (fr) Méthodes pour traiter la douleur chronique ou réfractaire et/ou pour augmenter le seuil de la douleur chez un sujet, et compositions pharmaceutiques associées
FR2908042B1 (fr) Ensemble d'intubation monocanaliculonasal et/ou monocanaliculaire,notamment pour l'imperforation lacrymonasale.
BRPI0722057A2 (pt) Composto, prodroga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono, e, uso do composto.
FR2950252B1 (fr) Forme galenique capable d'adsorber de maniere specifique les molecules indesirables
BRPI0905914A2 (pt) Máquina de tratamento para garrafas ou recipientes similares"
EP2218503A4 (fr) Catalyseur d'électrode et électrode de réduction d'oxygène pour électrode positive utilisant le catalyseur d'électrode
FR2946535B1 (fr) Composition comprenant une molecule favorisant l'interaction neurone-glie, notamment pour prevenir la formation de la cicatrice gliale et induire la regeneration neurale.
BRPI0807880A2 (pt) Composição anestésica em spray.
BRPI0916080A2 (pt) "composição de limpeza pessoal líquida ou sólido-macia"
WO2007109152A3 (fr) Lipophiles à fonctionnalité amine/amide

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140228